Procyrion, Inc.

Procyrion, Inc. company information, Employees & Contact Information

Explore related pages

Related company profiles:

Procyrion is dedicated to improving outcomes for patients with cardiac and renal impairment using its catheter-deployed pump technology to address conditions with significant unmet needs. Aortix™ is a percutaneous mechanical circulatory support device that treats cardiorenal syndrome with a rapidly-deployed intra-aortic catheter-based system. Aortix™ is currently in the research and development phase and is not available for sale in any country. (Caution: investigational device. Limited by federal law to investigational use.)

Company Details

Employees
31
Founded
-
Address
3900 Essex Lane, Houston,tx 77027,united States
Industry
Medical Equipment Manufacturing
NAICS
Medical Equipment and Supplies Manufacturing
Surgical and Medical Instrument Manufacturing
Surgical Appliance and Supplies Manufacturing
Dental Equipment and Supplies Manufacturing
Ophthalmic Goods Manufacturing
Dental Laboratories
HQ
Houston, TX
Looking for a particular Procyrion, Inc. employee's phone or email?

Procyrion, Inc. Questions

News

Procyrion Closes $57.7 Million in Series E Financing - PR Newswire

Procyrion Closes $57.7 Million in Series E Financing PR Newswire

Continuous-Flow Intra-Aortic Percutaneous Mechanical Circulatory Support in Heart Failure With Worsening Renal Function - American Heart Association Journals

Continuous-Flow Intra-Aortic Percutaneous Mechanical Circulatory Support in Heart Failure With Worsening Renal Function American Heart Association Journals

Procyrion Announces First Patient Enrollments in the DRAIN-HF Pivotal IDE Trial for Aortix Percutaneous Mechanical Circulatory Support Technology - Diagnostic and Interventional Cardiology

Procyrion Announces First Patient Enrollments in the DRAIN-HF Pivotal IDE Trial for Aortix Percutaneous Mechanical Circulatory Support Technology Diagnostic and Interventional Cardiology

Procyrion raises $57M to complete development of its percutaneous heart failure pump - Fierce Biotech

Procyrion raises $57M to complete development of its percutaneous heart failure pump Fierce Biotech

Heart failure specialists raise $58M for new device designed to improve cardiac, renal function - Cardiovascular Business

Heart failure specialists raise $58M for new device designed to improve cardiac, renal function Cardiovascular Business

Procyrion enrolls first patient in IDE trial for mechanical circulatory support tech - MassDevice

Procyrion enrolls first patient in IDE trial for mechanical circulatory support tech MassDevice

Procyrion secures $57.7m in Series E funding for Aortix device - Medical Device Network

Procyrion secures $57.7m in Series E funding for Aortix device Medical Device Network

Houston medical device company secures $57.7M to fund journey to FDA approval, commercialization - InnovationMap

Houston medical device company secures $57.7M to fund journey to FDA approval, commercialization InnovationMap

FDA grants breakthrough status to Procyrion’s cardiac device - MedTech Dive

FDA grants breakthrough status to Procyrion’s cardiac device MedTech Dive

Giving the Heart a Rest - TMC Houston

Giving the Heart a Rest TMC Houston

Medical device firm Procyrion passes key FDA milestone - Houston Chronicle

Medical device firm Procyrion passes key FDA milestone Houston Chronicle

Circulatory support without surgery for heart failure patients - Medical Design & Outsourcing

Circulatory support without surgery for heart failure patients Medical Design & Outsourcing

Procyrion Announces Appointment of Lucas Buchanan to Board of Directors - PR Newswire

Procyrion Announces Appointment of Lucas Buchanan to Board of Directors PR Newswire

Continuous-Flow Intra-Aortic Percutaneous Mechanical Circulatory Support in Heart Failure With Worsening Renal Function - American Heart Association Journals

Continuous-Flow Intra-Aortic Percutaneous Mechanical Circulatory Support in Heart Failure With Worsening Renal Function American Heart Association Journals

Procyrion Receives FDA Breakthrough Device Designation for Aortix System - Diagnostic and Interventional Cardiology

Procyrion Receives FDA Breakthrough Device Designation for Aortix System Diagnostic and Interventional Cardiology

Procyrion treats first patients with Aortix device in pilot study - Medical Device Network

Procyrion treats first patients with Aortix device in pilot study Medical Device Network

Procyrion bags $30M to push heart failure pump through the clinic - Fierce Biotech

Procyrion bags $30M to push heart failure pump through the clinic Fierce Biotech

Abdominal Positioning of the Next-Generation Intra-Aortic Fluid Entrainment Pump (Aortix) Improves Cardiac Output in a Swine Model of Heart Failure - American Heart Association Journals

Abdominal Positioning of the Next-Generation Intra-Aortic Fluid Entrainment Pump (Aortix) Improves Cardiac Output in a Swine Model of Heart Failure American Heart Association Journals

Aortix Heart Failure Pump Chosen for TCT “Shark Tank” Competition - Diagnostic and Interventional Cardiology

Aortix Heart Failure Pump Chosen for TCT “Shark Tank” Competition Diagnostic and Interventional Cardiology

Procyrion’s Aortix device could heighten heart pump competition - MassDevice

Procyrion’s Aortix device could heighten heart pump competition MassDevice

Transcatheter Pump May Aid Heart Failure Patients - Diagnostic and Interventional Cardiology

Transcatheter Pump May Aid Heart Failure Patients Diagnostic and Interventional Cardiology

This Tiny Heart Pump Can Be Inserted Nonsurgically - Bloomberg

This Tiny Heart Pump Can Be Inserted Nonsurgically Bloomberg

Procyrion's micro-heart pump moving forward - Today's Medical Developments

Procyrion's micro-heart pump moving forward Today's Medical Developments

FDA Breakthrough Device Designation for Aortix - Today's Medical Developments

FDA Breakthrough Device Designation for Aortix Today's Medical Developments

Here's what Houston startups have raised in funding so far in 2024 - InnovationMap

Here's what Houston startups have raised in funding so far in 2024 InnovationMap

Helping the heart heal itself - Today's Medical Developments

Helping the heart heal itself Today's Medical Developments

Big winners: 5 Houston companies that raised the most funding in 2024 - InnovationMap

Big winners: 5 Houston companies that raised the most funding in 2024 InnovationMap

Catheter-Based Heart Failure Pump Wins Innovative Technology Design Competition - Diagnostic and Interventional Cardiology

Catheter-Based Heart Failure Pump Wins Innovative Technology Design Competition Diagnostic and Interventional Cardiology

Study Testing Procyrions' Catheter-deployed Vascular Device for Cardiovascular Disease Presented at ACC.15 - cardiovasculardiseasenews.com

Study Testing Procyrions' Catheter-deployed Vascular Device for Cardiovascular Disease Presented at ACC.15 cardiovasculardiseasenews.com

Houston Startup To Present Abstract Describing Intravascular Blood Pump At Conference - cardiovasculardiseasenews.com

Houston Startup To Present Abstract Describing Intravascular Blood Pump At Conference cardiovasculardiseasenews.com

Motors Help Developers Modify Medical Devices for Kids - Design World

Motors Help Developers Modify Medical Devices for Kids Design World

Startup studio overcoming an entrepreneur shortage - Houston Chronicle

Startup studio overcoming an entrepreneur shortage Houston Chronicle

Top Procyrion, Inc. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant